Events
![](/upload/resize_cache/iblock/593/386_220_2/593b2b2d47d186c50792461b50d3b0c0.jpg)
Press Center
![](/upload/resize_cache/iblock/925/140_80_2/925b770090da366b082d5171a6f879ef.jpg)
19.02.2016
NPO Petrovax Pharm concluded a trilateral agreement regarding strategic cooperation to localize the production of the Russian flu vaccine Grippol Plus in Iran.
More
Topics Petrovax Pharm